Medtronic has expanded its Valiant Thoracic Stent Graft product offering to include six new 22mm stent graft configurations. It is anticipated that the 22mm Valiant stent graft will primarily address the treatment of traumatic thoracic aortic transections (TAT).
Medtronic has also recently launched the Talent Thoracic Stent Graft on the Xcelerant Delivery System, which, according to the company, makes minimally-invasive treatment of thoracic aortic aneurysm easier to perform. Recently approved by the FDA, the Talent Thoracic Stent Graft with the new delivery system is now available in the US. Features include a wide range of sizes so more patients can be treated; improved trackability and controlled deployment for easier and more accurate stent graft placement; and high radial force.
"The combination of the Xcelerant Hydro Delivery System and the Talent Abdominal Stent Graft represents another major step forward for the treatment of patients with abdominal aortic aneurysms," said Dr Manish Mehta, Albany Medical College and Albany Medical Center Hospital in New York. "The hydrophilic coating takes deliverability to a new level and gives endovascular interventionalists like me greater control over the deployment of this excellent stent graft, which has no equal in terms of sizes and profile. Taken together, these technologies simplify the procedure and enhance patient care – a powerful combination indeed."
Meditronic showcased the device at the VEITHsymposium 2008.